Loading...
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effective in controlling HIV-1 infections, new drug ta...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Libertas Academica
2007
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3155237/ https://ncbi.nlm.nih.gov/pubmed/21901072 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|